Wellspan Ephrata Community Hospital | |
169 Martin Avenue, Ephrata, Pennsylvania 17522 | |
(717) 733-0311 | |
Name | Wellspan Ephrata Community Hospital |
---|---|
Type | Acute Care Hospital |
Location | 169 Martin Avenue, Ephrata, Pennsylvania |
Ownership | Voluntary non-profit - Other |
Emergency Services | Yes |
Medicare ID (CCN) | 390225 |
NPI Number | 1497192975 |
Organization Name | EPHRATA CENTER FOR HEART CARE |
Doing Business As | EPHRATA COMMUNITY HOSPITAL |
Address | 169 Martin Ave Ste 179, Ephrata, PA 17522 |
Hospital Type | General Acute Care Hospital - Rural |
Phone Number | 717-721-5868 |
News Archive
Neurodegenerative diseases such as Alzheimer's or Parkinson's are characterised by the loss of nerve cells and the deposition of proteins in the brain tissue. A group of researchers led by Gabor G. Kovacs from the Clinical Institute of Neurology at the MedUni Vienna has now demonstrated that Alzheimer's disease does not just - as previously believed - involve the proteins that are attributed to Alzheimer's, but instead the condition can involve a mixture of interacting proteins from different neurodegenerative diseases.
Katja Lemburg discusses the next generation Hemo Control being launched in Europe at EuroMedLab, Paris 21-25th June.
The novel coronavirus SARS-CoV-2, also known as 2019-nCoV, is the virus that causes COVID-19, and that is spreading throughout the world is causing panic in almost all countries. With a death rate ranging from 1% to 2% in young patients but about 5%-8% in elderly and sick patients, it is capable of ravaging multiple organ systems in the human body.
A new preprint research paper posted to the bioRxiv server demonstrates the potential of using the pre-existing protective responses to produce a broad-spectrum neutralizing response against not just SARS-CoV-2 but other future pathogens.
› Verified 5 days ago
NPI Number | 1780819102 |
Organization Name | EPHRATA COMMUNITY HOSPITAL |
Address | 169 Martin Ave, Ephrata, PA 17522 |
Hospital Type | General Acute Care Hospital |
Phone Number | 717-733-5691 |
News Archive
Neurodegenerative diseases such as Alzheimer's or Parkinson's are characterised by the loss of nerve cells and the deposition of proteins in the brain tissue. A group of researchers led by Gabor G. Kovacs from the Clinical Institute of Neurology at the MedUni Vienna has now demonstrated that Alzheimer's disease does not just - as previously believed - involve the proteins that are attributed to Alzheimer's, but instead the condition can involve a mixture of interacting proteins from different neurodegenerative diseases.
Katja Lemburg discusses the next generation Hemo Control being launched in Europe at EuroMedLab, Paris 21-25th June.
The novel coronavirus SARS-CoV-2, also known as 2019-nCoV, is the virus that causes COVID-19, and that is spreading throughout the world is causing panic in almost all countries. With a death rate ranging from 1% to 2% in young patients but about 5%-8% in elderly and sick patients, it is capable of ravaging multiple organ systems in the human body.
A new preprint research paper posted to the bioRxiv server demonstrates the potential of using the pre-existing protective responses to produce a broad-spectrum neutralizing response against not just SARS-CoV-2 but other future pathogens.
› Verified 5 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Neurodegenerative diseases such as Alzheimer's or Parkinson's are characterised by the loss of nerve cells and the deposition of proteins in the brain tissue. A group of researchers led by Gabor G. Kovacs from the Clinical Institute of Neurology at the MedUni Vienna has now demonstrated that Alzheimer's disease does not just - as previously believed - involve the proteins that are attributed to Alzheimer's, but instead the condition can involve a mixture of interacting proteins from different neurodegenerative diseases.
Katja Lemburg discusses the next generation Hemo Control being launched in Europe at EuroMedLab, Paris 21-25th June.
The novel coronavirus SARS-CoV-2, also known as 2019-nCoV, is the virus that causes COVID-19, and that is spreading throughout the world is causing panic in almost all countries. With a death rate ranging from 1% to 2% in young patients but about 5%-8% in elderly and sick patients, it is capable of ravaging multiple organ systems in the human body.
A new preprint research paper posted to the bioRxiv server demonstrates the potential of using the pre-existing protective responses to produce a broad-spectrum neutralizing response against not just SARS-CoV-2 but other future pathogens.
› Verified 5 days ago
Wellspan Ephrata Community Hospital Acute Care Hospital Location: 169 Martin Avenue, Ephrata, Pennsylvania 17522 Phone: (717) 733-0311 |